Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testis | 5 | 2020 | 185 | 0.470 |
Why?
|
| Spermatogonia | 3 | 2007 | 56 | 0.370 |
Why?
|
| Ribonucleoproteins, Small Nucleolar | 1 | 2007 | 1 | 0.310 |
Why?
|
| Cell Differentiation | 3 | 2007 | 562 | 0.310 |
Why?
|
| Testosterone | 6 | 2011 | 181 | 0.280 |
Why?
|
| Mutation | 1 | 2007 | 1023 | 0.220 |
Why?
|
| Spermatogenesis | 3 | 2011 | 154 | 0.220 |
Why?
|
| Goats | 1 | 2020 | 21 | 0.190 |
Why?
|
| Aging | 2 | 2020 | 639 | 0.190 |
Why?
|
| Semen Analysis | 1 | 2019 | 3 | 0.180 |
Why?
|
| Fertility | 1 | 2019 | 59 | 0.180 |
Why?
|
| Cattle | 2 | 2019 | 472 | 0.170 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 968 | 0.160 |
Why?
|
| Spermatozoa | 1 | 2019 | 191 | 0.160 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2009 | 41 | 0.160 |
Why?
|
| Mitochondria | 1 | 2020 | 454 | 0.150 |
Why?
|
| Luteinizing Hormone | 2 | 2009 | 62 | 0.150 |
Why?
|
| MicroRNAs | 2 | 2019 | 386 | 0.140 |
Why?
|
| Estradiol | 2 | 2011 | 244 | 0.140 |
Why?
|
| Gonadotropin-Releasing Hormone | 4 | 2011 | 29 | 0.140 |
Why?
|
| Oxidative Stress | 1 | 2020 | 874 | 0.130 |
Why?
|
| Crosses, Genetic | 2 | 2011 | 48 | 0.100 |
Why?
|
| Diethylstilbestrol | 1 | 2009 | 6 | 0.090 |
Why?
|
| Ethinyl Estradiol | 1 | 2009 | 9 | 0.090 |
Why?
|
| Teratogens | 1 | 2009 | 12 | 0.090 |
Why?
|
| Estrogens | 1 | 2011 | 190 | 0.090 |
Why?
|
| Animals | 9 | 2020 | 14307 | 0.090 |
Why?
|
| Infertility, Male | 1 | 2009 | 44 | 0.090 |
Why?
|
| Penis | 1 | 2009 | 72 | 0.090 |
Why?
|
| Animals, Newborn | 1 | 2009 | 323 | 0.080 |
Why?
|
| Scrotum | 1 | 2007 | 4 | 0.080 |
Why?
|
| Mice, Inbred C3H | 1 | 2007 | 83 | 0.080 |
Why?
|
| Homozygote | 1 | 2007 | 75 | 0.080 |
Why?
|
| Body Temperature | 1 | 2007 | 39 | 0.080 |
Why?
|
| Heterozygote | 1 | 2007 | 91 | 0.080 |
Why?
|
| Cell Count | 1 | 2007 | 129 | 0.070 |
Why?
|
| Y Chromosome | 1 | 2007 | 49 | 0.070 |
Why?
|
| Chromosome Mapping | 1 | 2007 | 159 | 0.070 |
Why?
|
| Male | 8 | 2020 | 18870 | 0.070 |
Why?
|
| Species Specificity | 1 | 2007 | 233 | 0.070 |
Why?
|
| Insulin | 2 | 2011 | 224 | 0.070 |
Why?
|
| Flutamide | 3 | 2011 | 7 | 0.070 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2004 | 11 | 0.060 |
Why?
|
| Rats | 5 | 2011 | 3261 | 0.060 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2002 | 19 | 0.060 |
Why?
|
| Steroids | 1 | 2002 | 43 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2002 | 66 | 0.050 |
Why?
|
| Ovary | 1 | 2002 | 101 | 0.050 |
Why?
|
| Gamma Rays | 2 | 2011 | 25 | 0.050 |
Why?
|
| Oligopeptides | 2 | 2011 | 97 | 0.050 |
Why?
|
| Breeding | 1 | 2019 | 21 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2019 | 72 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 298 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 139 | 0.040 |
Why?
|
| Computational Biology | 1 | 2019 | 275 | 0.040 |
Why?
|
| Mice | 1 | 2007 | 5668 | 0.040 |
Why?
|
| Rats, Inbred Lew | 1 | 2011 | 21 | 0.030 |
Why?
|
| Rats, Inbred BN | 1 | 2011 | 19 | 0.030 |
Why?
|
| Hormone Antagonists | 1 | 2011 | 15 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2011 | 19 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 217 | 0.020 |
Why?
|
| Organ Size | 1 | 2009 | 148 | 0.020 |
Why?
|
| Germ Cells | 1 | 2009 | 70 | 0.020 |
Why?
|
| Proteins | 1 | 2011 | 352 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 605 | 0.020 |
Why?
|
| Body Weight | 1 | 2009 | 404 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 984 | 0.020 |
Why?
|
| Hypophysectomy | 1 | 2005 | 4 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 600 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 2004 | 132 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2004 | 89 | 0.020 |
Why?
|
| Hormones | 1 | 2004 | 51 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 485 | 0.020 |
Why?
|
| Metalloendopeptidases | 1 | 2002 | 15 | 0.010 |
Why?
|
| Endothelium | 1 | 2002 | 31 | 0.010 |
Why?
|
| Ovarian Follicle | 1 | 2002 | 31 | 0.010 |
Why?
|
| Endothelin-1 | 1 | 2002 | 54 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2002 | 149 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2002 | 420 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2002 | 490 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2002 | 1442 | 0.010 |
Why?
|
| Female | 2 | 2009 | 19873 | 0.010 |
Why?
|
| Humans | 1 | 2005 | 34853 | 0.000 |
Why?
|